Stock Scorecard



Stock Summary for Agilon Health Inc (AGL) - $90.65 as of 10/28/2026 7:05:13 PM EST

Total Score

11 out of 30

Safety Score

34 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for AGL

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AGL

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AGL

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for AGL

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for AGL (34 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 5
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for AGL

agilon health, inc. Estimates – NYSE:AGL 10/23/2026 5:41:00 PM
agilon health (AGL): Buy, Sell, or Hold Post Q2 Earnings? 10/21/2026 5:10:00 AM
A Look at Agilon Health Inc (AGL) After 4.4% Gain -- GF Value $9 10/19/2026 11:42:00 PM
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know 10/19/2026 6:06:00 PM
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know 10/19/2026 2:05:00 PM
Agilon Health (AGL) Short Interest & Short Float | Updated Oct 2026 $AGL 10/16/2026 6:44:00 PM
Is It Too Late to Buy Agilon Health Inc (AGL) After 3.8% Rally? GF Value Says Undervalued 10/13/2026 12:11:00 AM
Bernstein Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $125 10/6/2026 4:01:00 AM
A 4:30 p.m. call will cover agilon health's third-quarter results on Nov. 4. 10/6/2026 12:26:00 AM
agilon health Sets Date to Report Third Quarter 2026 Financial Results 10/5/2026 3:05:00 PM

Financial Details for AGL

Company Overview

Ticker AGL
Company Name Agilon Health Inc
Country USA
Description agilon health, inc. The company is headquartered in Long Beach, California.
Sector Name HEALTHCARE
Industry Name MEDICAL CARE FACILITIES
Most Recent Quarter 6/30/2026
Next Earnings Date 11/4/2026

Stock Price History

Last Day Price 90.65
Price 4 Years Ago 403.50
Last Day Price Updated 10/28/2026 7:05:13 PM EST
Last Day Volume 123,836
Average Daily Volume 217,108
52-Week High 133.04
52-Week Low 7.48
Last Price to 52 Week Low 1,111.90%

Valuation Measures

Trailing PE N/A
Industry PE 60.91
Sector PE 48.27
5-Year Average PE -1,364.51
Free Cash Flow Ratio 14.21
Industry Free Cash Flow Ratio 46.24
Sector Free Cash Flow Ratio 37.95
Current Ratio Most Recent Quarter 1.08
Total Cash Per Share 6.38
Book Value Per Share Most Recent Quarter 13.55
Price to Book Ratio 6.62
Industry Price to Book Ratio 29.20
Sector Price to Book Ratio 32.63
Price to Sales Ratio Twelve Trailing Months 0.26
Industry Price to Sales Ratio Twelve Trailing Months 1.05
Sector Price to Sales Ratio Twelve Trailing Months 22.96
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 16,791,200
Market Capitalization 1,522,122,280
Institutional Ownership 97.19%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 301.00%
Annual Earnings Growth -55.81%
Reported EPS 12 Trailing Months -15.29
Reported EPS Past Year 2.18
Reported EPS Prior Year -12.66
Net Income Twelve Trailing Months -251,161,000
Net Income Past Year -405,347,000
Net Income Prior Year -260,151,000
Quarterly Revenue Growth YOY 7.20%
5-Year Revenue Growth 37.24%
Operating Margin Twelve Trailing Months 1.30%

Balance Sheet

Total Cash Most Recent Quarter 107,184,000
Total Cash Past Year 173,713,000
Total Cash Prior Year 193,860,000
Net Cash Position Most Recent Quarter 91,807,000
Net Cash Position Past Year 157,963,000
Long Term Debt Past Year 15,750,000
Long Term Debt Prior Year 34,904,000
Total Debt Most Recent Quarter 15,377,000
Equity to Debt Ratio Past Year 0.89
Equity to Debt Ratio Most Recent Quarter 0.94
Total Stockholder Equity Past Year 126,734,000
Total Stockholder Equity Prior Year 470,952,000
Total Stockholder Equity Most Recent Quarter 227,527,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -112,378,000
Free Cash Flow Per Share Twelve Trailing Months -6.69
Free Cash Flow Past Year -119,005,000
Free Cash Flow Prior Year -71,028,000

Options

Put/Call Ratio 1.67
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band -2.98
20-Day Bollinger Middle Band 76.11
20-Day Bollinger Upper Band 155.20
Beta 3.00
RSI 39.41
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 10/28/2026 4:54:32 PM EST